Latest Options News

Buru Energy reminds shareholders that its Share Purchase Plan closes on 7 October, offering shares at 2 cents each plus attaching options subject to approval.

Olympio Metals has completed a substantial diamond drilling program at its Bousquet Project in Quebec, revealing promising high-grade gold intersections at the Paquin Prospect and highlighting significant down dip potential along the Cadillac Break.

TPC Consolidated and Wollar Solar Holding have agreed to extend key deadlines in their acquisition scheme as they await crucial FIRB approval, pushing the timeline into early 2026.

Rio Tinto Limited has updated its dividend reinvestment plan details, announcing a DRP share price of AUD 121.97 and an allocation date of 2 October 2025 for its fully franked interim dividend.

Variscan Mines has successfully completed the majority of the second tranche of its $2.5 million capital raise, issuing over 330 million shares and nearly 200 million options to support its zinc-lead project in Spain.

Future Metals NL has appointed seasoned resources executive Keith Bowes as Managing Director and CEO, aiming to accelerate development of its flagship Panton and Eileen Bore projects.

Altamin Limited has launched a $6.46 million retail entitlement offer to fund exploration at its Lazio Project and maintain the Gorno Project. Eligible shareholders can subscribe to new shares at $0.025 each on a 45-for-100 basis.

Imagion Biosystems has completed the second tranche of its $3.5 million placement, raising $2.85 million to advance its proprietary MagSense® imaging technology targeting breast, prostate, and ovarian cancers.

AssetOwl Limited has locked in a $281,654 convertible note funding from a related party, adding to its financing options as it navigates shareholder approval and potential share dilution.

CurveBeam AI Limited has secured A$6.5 million in new capital to fuel global growth of its HiRise™ weight-bearing CT scanner, deepen its partnership with orthopaedic giant Stryker, and advance a potential strategic deal in China.

Mayne Pharma’s innovative oral contraceptive NEXTSTELLIS® has secured reimbursement under Australia’s Pharmaceutical Benefits Scheme, making it significantly more affordable and broadening contraceptive options nationwide.

Emu NL has bolstered its financial footing through a $590,000 rights issue and the sale of its Badja Gold Project, setting the stage for a maiden drilling program at its Yataga Copper Project. Leadership changes signal a new chapter as drilling preparations near completion.